Clinical review: Ketones and brain injury

Critical Care

Volumn 15, Issue 2, 2011, Pages

  White, Hayden ^a   Venkatesh, Balasubramanian ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KETONE; KETONE BODY; KTX 0101; SODIUM CHLORIDE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

BRAIN METABOLISM; CRITICAL ILLNESS; DRUG ACTIVITY; HUMAN; INTRACRANIAL HYPERTENSION; MEDICAL RESEARCH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; METABOLISM;

ANIMALS; BRAIN INJURIES; CRITICAL ILLNESS; HUMANS; KETONE BODIES; KETONES; NEUROPROTECTIVE AGENTS;

EID: 84862739428     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10020     Document Type: Review

References (102)

1. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004, 70:243-251. 10.1016/j.plefa.2003.11.001, 14769483.
2. DeFronzo R, Ferrannini E. Regulation of intermediary metabolism during fasting and feeding. Endocrinology 2001, 737-755. Philadelphia: W.B. Saunders, DeGroot L, Jameson J.
3. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70:309-319. 10.1016/j.plefa.2003.09.007, 14769489.
4. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamideadenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967, 103:514-527. 1270436, 4291787.
5. Veech RL, Eggleston LV, Krebs HA. The redox state of free nicotinamideadenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 1969, 115:609-619. 1185185, 4391039.
6. Bonnefont JP, Specola NB, Vassault A, Lombes A, Ogier H, de Klerk JB, Munnich A, Coude M, Paturneau-Jouas M, Saudubray JM. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990, 150:80-85. 10.1007/BF02072043, 2279514.
7. Cahill GF, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA, Kipnis DM. Hormone-fuel interrelationships during fasting. J Clin Invest 1966, 45:1751-1769. 10.1172/JCI105481, 292859, 5926444.
8. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF. Liver and kidney metabolism during prolonged starvation. J Clin Invest 1969, 48:574-583. 10.1172/JCI106016, 535723, 5773093.
9. Garber AJ, Menzel PH, Boden G, Owen OE. Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest 1974, 54:981-989. 10.1172/JCI107839, 301639, 4430728.
10. Williamson DH. Ketone body production and metabolism in the fetus and newborn. Neonatal Physiology 1992, 330-340. Philadelphia: W.B. Saunders, Polin R, Fox W.
11. Balasse EO, Fery F. Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 1989, 5:247-270. 10.1002/dmr.5610050304, 2656155.
12. Hawkins RA. Uptake of ketone bodies by rat brain in vivo. Biochem J 1971, 121:17P. 1176528, 5116532.
13. Williamson DH, Bates MW, Page MA, Krebs HA. Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J 1971, 121:41-47. 1176484, 5165621.
14. Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 2007, 35:S441-S448. 10.1097/01.CCM.0000278049.48333.78, 17713391.
15. Yassen KA, Galley HF, Lee A, Webster NR. Mitochondrial redox state in the critically ill. Br J Anaesth 1999, 83:325-327.
16. Limuro Y, Yamamoto M, Inoue S, Kohno H, Matsumoto Y. Superoxide production by liver macrophages in septic shock model - relation to arterial ketone body ratio. Eur Surg Res 1992, 24:363-371. 10.1159/000129229, 1338046.
17. Dresing K, Armstrong VW, Leip CL, Streit F, Burchardi H, Sturmer KM, Oellerich M. Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. Clin Biochem 2007, 40:1194-1200. 10.1016/j.clinbiochem.2007.06.013, 17707362.
18. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 2000, 28:114-119. 10.1097/00003246-200001000-00019, 10667509.
19. Pellerin L. How astrocytes feed hungry neurons. Mol Neurobiol 2005, 32:59-72. 10.1385/MN:32:1:059, 16077184.
20. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting. J Clin Invest 1967, 46:1589-1595. 10.1172/JCI105650, 292907, 6061736.
21. Casazza JP, Felver ME, Veech RL. The metabolism of acetone in rat. J Biol Chem 1984, 259:231-236.
22. VanItallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutr Rev 2003, 61:327-341. 10.1301/nr.2003.oct.327-341, 14604265.
23. Reichard GA, Owen OE, Haff AC, Paul P, Bortz WM. Ketone-body production and oxidation in fasting obese humans. J Clin Invest 1974, 53:508-515. 10.1172/JCI107584, 301493, 11344564.
24. Guzman M, Blazquez C. Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 2004, 70:287-292. 10.1016/j.plefa.2003.05.001, 14769487.
25. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991, 56:1376-1386. 10.1111/j.1471-4159.1991.tb11435.x, 2002348.
26. Bixel MG, Hamprecht B. Generation of ketone bodies from leucine by cultured astroglial cells. J Neurochem 1995, 65:2450-2461. 10.1046/j.1471-4159.1995.65062450.x, 7595539.
27. Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS. Lipoproteins in the central nervous system. Ann N Y Acad Sci 2000, 903:167-175. 10.1111/j.1749-6632.2000.tb06365.x, 10818504.
28. Lopes-Cardozo M, Larsson OM, Schousboe A. Acetoacetate and glucose as lipid precursors and energy substrates in primary cultures of astrocytes and neurons from mouse cerebral cortex. J Neurochem 1986, 46:773-778. 10.1111/j.1471-4159.1986.tb13039.x, 3081684.
29. Guzman M, Blazquez C. Is there an astrocyte-neuron ketone body shuttle?. Trends Endocrinol Metab 2001, 12:169-173. 10.1016/S1043-2760(00)00370-2, 11295573.
30. Pellerin L, Pellegri G, Martin JL, Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc Natl Acad Sci USA 1998, 95:3990-3995. 10.1073/pnas.95.7.3990, 19950, 9520480.
31. Pope A. Neurolgia: quantitative aspects. Dynamic Properties of Glial Cells: An Interdisciplinary Approach to their Study in the Central and Peripheral Nervous System 1978, 13-20. New York: Pergamon Press, Schoff eniels E, Tower F.
32. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 2001, 38:519-527. 10.1016/S0197-0186(00)00102-9, 11248400.
33. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 1994, 14:125-131.
34. Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP. Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 2000, 20:1502-1507. 10.1097/00004647-200010000-00012, 11043913.
35. Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP. Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001, 79:539-544. 10.1046/j.1471-4159.2001.00575.x, 11701757.
36. Kante A, Cherkaoui Malki M, Coquard C, Latruffe N. Metabolic control of the expression of mitochondrial D-beta-hydroxybutyrate dehydrogenase, a ketone body converting enzyme. Biochim Biophys Acta 1990, 1033:291-297.
37. Smith AL, Satterthwaite HS, Sokoloff L. Induction of brain D(-)-betahydroxybytrate dehydrogenase activity by fasting. Science 1969, 163:79-81. 10.1126/science.163.3862.79, 4975341.
38. Gjedde A, Crone C. Induction processes in blood-brain transfer of ketone Bodies during starvation. Am J Physiol 1975, 229:1165-1169.
39. Moore TJ, Lione AP, Sugden MC, Regen DM. Beta-hydroxybutyrate transport in rat brain: developmental and dietary modulations. Am J Physiol 1976, 230:619-630.
40. Hawkins RA, Mans AM, Davis DW. Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986, 250:E169-E178.
41. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28:109-121. 10.1007/s10545-005-5518-0, 15877199.
42. Hawkins RA, Biebuyck JF. Ketone bodies are selectively used by individual brain regions. Science 1979, 205:325-327. 10.1126/science.451608, 451608.
43. Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 2008, 28:1-16. 10.1038/sj.jcbfm.9600543, 2857668, 17684514.
44. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF. Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247. 10.1080/152165401753311780, 11569918.
45. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV. Control of glucose utilization in working perfused rat heart. J Biol Chem 1994, 269:25502-25514.
46. Krebs HA, Veech RL. Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv Enzyme Regul 1969, 7:397-413. 10.1016/0065-2571(69)90030-2, 4391643.
47. Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araujo E, Torres IL, Gottfried C, Netto CA, Goncalves CA. Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 2003, 28:1793-1797. 10.1023/A:1026107405399, 14649719.
48. Gasior M, Rogawski MA, Hartman AL. Neuroprotective and diseasemodifying effects of the ketogenic diet. Behav Pharmacol 2006, 17:431-439. 10.1097/00008877-200609000-00009, 2367001, 16940764.
49. Yudkoff M, Daikhin Y, Nissim I, Lazarow A. Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001, 66:931-940. 10.1002/jnr.10083, 11746421.
50. Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol 1996, 270:E746-E751.
51. Prins ML, Giza CC. Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev Neurosci 2006, 28:447-456. 10.1159/000094170, 16943667.
52. Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, Naini A, Vila M, Jackson-Lewis V, Ramasamy R, Przedborski S. D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003, 112:892-901. 193668, 12975474.
53. Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, Margulies D. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 2009, 75:25-29.
54. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145:256-264. 10.1016/j.neuroscience.2006.11.065, 1865572, 17240074.
55. Massieu L, Haces ML, Montiel T, Hernandez-Fonseca K. Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 2003, 120:365-378. 10.1016/S0306-4522(03)00266-5, 12890508.
56. Mejia-Toiber J, Montiel T, Massieu L. D-β-Hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem Res 2006, 31:1399-1408. 10.1007/s11064-006-9189-5, 17115265.
57. Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, Shin HS, Kang SS, Cho GJ, Choi WS. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J Neurosci Res 2006, 84:1829-1836. 10.1002/jnr.21057, 17058267.
58. Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, Cho GJ, Choi WS. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 2003, 53:119-128. 10.1016/S0920-1211(02)00262-0, 12576173.
59. Masuda R, Monahan JW, Kashiwaya Y. D-β-Hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 2005, 80:501-509. 10.1002/jnr.20464, 15825191.
60. Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, LaManna JC. Adaptation to chronic hypoxia during diet-induced ketosis. Adv Exp Med Biol 2005, 566:51-57. full_text, 16594134.
61. Hu ZG, Wang HD, Jin W, Yin HX. Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Ann Clin Lab Sci 2009, 39:76-83.
62. Hu ZG, Wang HD, Qiao L, Yan W, Tan QF, Yin HX. The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Injury 2009, 23:459-465. 10.1080/02699050902788469, 19408168.
63. Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A. Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 2002, 89:36-43. 10.1254/jjp.89.36, 12083741.
64. Prins ML, Fujima LS, Hovda DA. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 2005, 82:413-420. 10.1002/jnr.20633, 16180224.
65. Prins ML, Lee SM, Fujima LS, Hovda DA. Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J Neurochem 2004, 90:666-672. 10.1111/j.1471-4159.2004.02542.x, 15255945.
66. Hall ED, Andrus PK, Yonkers PA. Brain hydroxyl radical generation in acute experimental head injury. J Neurochem 1993, 60:588-594. 10.1111/j.1471-4159.1993.tb03189.x, 8380437.
67. Biros MH, Nordness R. Eff ects of chemical pretreatment on posttraumatic cortical edema in the rat. Am J Emerg Med 1996, 14:27-32. 10.1016/S0735-6757(96)90008-X, 8630150.
68. Go KG, Prenen GH, Korf J. Protective effect of fasting upon cerebralhypoxic-ischemic injury. Metab Brain Dis 1988, 3:257-263. 10.1007/BF00999535, 3241603.
69. Marie C, Bralet AM, Gueldry S, Bralet J. Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab Brain Dis 1990, 5:65-75. 10.1007/BF01001047, 2385215.
70. Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol 2001, 87:143-150. 10.1254/jjp.87.143, 11700013.
71. Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K. D-β- Hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 2006, 84:1376-1384. 10.1002/jnr.21021, 16917840.
72. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-β- Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97:5440-5444. 10.1073/pnas.97.10.5440, 25847, 10805800.
73. Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ. Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem 2004, 279:51783-51792. 10.1074/jbc.M407336200, 15469939.
74. Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2005, 2:28. 10.1186/1743-7075-2-28, 1282589, 16229744.
75. Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV. D, L-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase defi ciency (MADD). Lancet 2003, 361:1433-1435. 10.1016/S0140-6736(03)13105-4, 12727399.
76. Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000, 15:787-790. 10.1177/088307380001501203, 11198492.
77. Smith SL, Heal DJ, Martin KF. KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev 2005, 11:113-140. 10.1111/j.1527-3458.2005.tb00265.x, 16007235.
78. Ritter AM, Robertson CS, Goodman JC, Contant CF, Grossman RG. Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 1996, 13:473-485. 10.1089/neu.1996.13.473, 8880611.
79. Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 2002, 283:E20-E28.
80. Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007, 302:249-256. 10.1007/s11010-007-9448-z, 17447017.
81. Hiraide A, Katayama M, Sugimoto H, Yoshioka T, Sugimoto T. Effect of 3-hydroxybutyrate on posttraumatic metabolism in man. Surgery 1991, 109:176-181.
82. Miles JM, Nissen SL, Rizza RA, Gerich JE, Haymond MW. Failure of infused beta-hydroxybutyrate to decrease proteolysis in man. Diabetes 1983, 32:197-205. 10.2337/diabetes.32.3.197, 6298041.
83. Owen OE, Reichard GA, Markus H, Boden G, Mozzoli MA, Shuman CR. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J Clin Invest 1973, 52:2606-2616. 10.1172/JCI107453, 302521, 4729054.
84. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004, 25:311-314. 10.1016/S0197-4580(03)00087-3, 15123336.
85. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995, 268:E1161-E1166.
86. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet - 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102:1358-1363. 10.1542/peds.102.6.1358, 9832569.
87. Kielb S, Koo HP, Bloom DA, Faerber GJ. Nephrolithiasis associated with the ketogenic diet. J Urol 2000, 164:464-466. 10.1016/S0022-5347(05)67400-9, 10893623.
88. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Initial management. J Neurotrauma 2000, 17:463-469. 10.1089/neu.2000.17.463, 10937888.
89. Bhardwaj A, Ulatowski JA. Cerebral edema: hypertonic saline solutions. Curr Treat Options Neurol 1999, 1:179-188. 10.1007/s11940-999-0002-z, 11096708.
90. Harukuni I, Kirsch JR, Bhardwaj A. Cerebral resuscitation: role of osmotherapy. J Anesth 2002, 16:229-237. 10.1007/s005400200030, 14517646.
91. Dubick MA, Wade CE. A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma 1994, 36:323-330. 10.1097/00005373-199403000-00007, 7511708.
92. Eilig I, Rachinsky M, Artru AA, Alonchin A, Kapuler V, Tarnapolski A, Shapira Y. The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats. Anesth Analg 2001, 92:669-675. 10.1097/00000539-200103000-00023, 11226099.
93. Gunnar W, Jonasson O, Merlotti G, Stone J, Barrett J. Head injury and hemorrhagic shock: studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988, 103:398-407.
94. Shackford SR. Effect of small-volume resuscitation on intracranial pressure and related cerebral variables. J Trauma 1997, 42:S48-S53. 10.1097/00005373-199705001-00009, 9191696.
95. Berger S, Schurer L, Hartl R, Deisbock T, Dautermann C, Murr R, Messmer K, Baethmann A. 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir Suppl (Wien) 1994, 60:494-498.
96. Mirski AM, Denchev ID, Schnitzer SM, Hanley FD. Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J Neurosurg Anesthesiol 2000, 12:334-344. 10.1097/00008506-200010000-00006, 11147382.
97. Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004, 291:1350-1357. 10.1001/jama.291.11.1350, 15026402.
98. Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, Holcroft JW. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993, 128:1003-1011. discussion 1011-1013.
99. Vassar MJ, Perry CA, Holcroft JW. Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. J Trauma 1993, 34:622-632. discussion 632-633, 10.1097/00005373-199305000-00003, 7684457.
100. Qureshi AI, Suarez JI, Bhardwaj A. Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon?. J Neurosurg Anesthesiol 1998, 10:188-192. 10.1097/00008506-199807000-00010, 9681408.
101. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, Ulatowski JA. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26:440-446. 10.1097/00003246-199803000-00011, 9504569.
102. Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S. Neurocardiac toxicity of racemic D, L-lactate fluids. Integr Physiol Behav Sci 1994, 29:383-394. 10.1007/BF02691358, 7696135.